NASDAQ:BDTX

Black Diamond Therapeutics Stock Forecast

etoro logo Buy BDTX
*Your capital is at risk
$1.70
-0.160 (-8.60%)
At Close: Jun 25, 2026
AI Analysis AI Analysis of BDTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BDTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Black Diamond Therapeutics Inc. stock price on Thursday which ended trading at $1.70
(Updated on Jun 25, 2026)

Sell candidate since May 22, 2026 Loss -25.44%

The Black Diamond Therapeutics Inc. stock price fell by -8.60% on the last day (Thursday, 25th Jun 2026) from $1.86 to $1.70. During the last trading day the stock fluctuated 11.83% from a day low at $1.69 to a day high of $1.89. The price has fallen in 8 of the last 10 days and is down by -8.11% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -940 thousand shares and in total, 2 million shares were bought and sold for approximately $3.26 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.38% during the next 3 months and, with a 90% probability hold a price between $0.91 and $2.56 at the end of this 3-month period.

BDTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Black Diamond Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.29. On a fall, the stock will find some support from the short-term average at $1.68. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -52.78%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Black Diamond Therapeutics Inc. stock

Black Diamond Therapeutics Inc. finds support from accumulated volume at $1.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.200 between high and low, or 11.83%. For the last week, the stock has had daily average volatility of 10.32%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BDTX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Black Diamond Therapeutics Inc. to open at $1.76, and during the day (based on 14 day Average True Range), to move between $1.61 and $1.79, which gives a possible trading interval of +/-$0.189 (+/-11.80%) up or down from last closing price. If Black Diamond Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.68 (1.18%) than the resistance at $1.75 (2.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Black Diamond Therapeutics Inc. stock A Buy?

Black Diamond Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.922 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $1.76 ( 3.53%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BDTX Performance

Trading levels for BDTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.96 15.29%
R2 1.88 10.80%
R1 1.84 8.02%
Price 1.70
S1 1.68 -0.96%
S2 1.64 -3.74%
S3 1.56 -8.24%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.86 9.41%
R2 1.85 8.82%
R1 1.75 2.94%
Price 1.70
S1 1.68 -1.18%
S2 1.66 -2.35%
S3 1.61 -5.29%

FAQ

What is the symbol for Black Diamond Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Black Diamond Therapeutics Inc. is BDTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Black Diamond Therapeutics Inc. Stock?
Black Diamond Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Black Diamond Therapeutics Inc. Stock?
Black Diamond Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Black Diamond Therapeutics Inc. Stock.

What's the current price of Black Diamond Therapeutics Inc. Stock?
As of the end of day on the Jun 25, 2026, the price of an Black Diamond Therapeutics Inc. (BDTX) share was $1.70.

What is the 52-week high and low for Black Diamond Therapeutics Inc. Stock?
The 52-week high for Black Diamond Therapeutics Inc. Stock is $4.94 and the 52-week low is $1.60.

What is the market capitalization of Black Diamond Therapeutics Inc. Stock?
As of the Jun 25, 2026, the market capitalization of Black Diamond Therapeutics Inc. is 97.413M.

When is the next earnings date for Black Diamond Therapeutics Inc.?
The upcoming earnings date for Black Diamond Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT BLACK DIAMOND THERAPEUTICS INC.
Black Diamond Therapeutics
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penet...
GOLDEN STAR
Ticker Change Signal Date
JLL
$298.94
1.61% Jun 23
CBRE
$133.21
1.03% Jun 23
CAG
$13.43
2.72% Jun 23
TTEK
$28.04
1.43% Jun 23
NESR
$25.07
7.62% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE